1. Home
  2. JBIO vs JMSB Comparison

JBIO vs JMSB Comparison

Compare JBIO & JMSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JBIO
  • JMSB
  • Stock Information
  • Founded
  • JBIO 2024
  • JMSB 2005
  • Country
  • JBIO United States
  • JMSB United States
  • Employees
  • JBIO N/A
  • JMSB N/A
  • Industry
  • JBIO
  • JMSB Major Banks
  • Sector
  • JBIO
  • JMSB Finance
  • Exchange
  • JBIO NYSE
  • JMSB Nasdaq
  • Market Cap
  • JBIO 290.1M
  • JMSB 282.0M
  • IPO Year
  • JBIO N/A
  • JMSB N/A
  • Fundamental
  • Price
  • JBIO $8.28
  • JMSB $19.11
  • Analyst Decision
  • JBIO Strong Buy
  • JMSB Buy
  • Analyst Count
  • JBIO 2
  • JMSB 2
  • Target Price
  • JBIO $15.50
  • JMSB $22.50
  • AVG Volume (30 Days)
  • JBIO 397.1K
  • JMSB 24.8K
  • Earning Date
  • JBIO 08-05-2025
  • JMSB 07-23-2025
  • Dividend Yield
  • JBIO N/A
  • JMSB 1.52%
  • EPS Growth
  • JBIO N/A
  • JMSB 687.32
  • EPS
  • JBIO N/A
  • JMSB 1.32
  • Revenue
  • JBIO N/A
  • JMSB $56,750,000.00
  • Revenue This Year
  • JBIO N/A
  • JMSB N/A
  • Revenue Next Year
  • JBIO N/A
  • JMSB N/A
  • P/E Ratio
  • JBIO N/A
  • JMSB $14.96
  • Revenue Growth
  • JBIO N/A
  • JMSB 59.00
  • 52 Week Low
  • JBIO $1.61
  • JMSB $13.81
  • 52 Week High
  • JBIO $13.50
  • JMSB $26.52
  • Technical
  • Relative Strength Index (RSI)
  • JBIO N/A
  • JMSB 54.20
  • Support Level
  • JBIO N/A
  • JMSB $18.88
  • Resistance Level
  • JBIO N/A
  • JMSB $19.95
  • Average True Range (ATR)
  • JBIO 0.00
  • JMSB 0.55
  • MACD
  • JBIO 0.00
  • JMSB -0.05
  • Stochastic Oscillator
  • JBIO 0.00
  • JMSB 53.33

About JBIO JADE BIOSCIENCES INC

Jade Biosciences Inc is focused on developing therapies to address critical unmet needs in autoimmune diseases. Its asset, JADE-001, will target the anti-A PRoliferation-Inducing Ligand (APRIL) pathway for immunoglobulin A (IgA) nephropathy, with Investigational New Drug Application-enabling studies underway and initiation of a first-in-human trial. Jade's pipeline also includes two undisclosed optimized antibody discovery programs, JADE-002 and JADE-003, currently in preclinical development. Jade was launched based on assets licensed from Paragon Therapeutics, an antibody discovery engine founded by Fairmount.

About JMSB John Marshall Bancorp Inc.

John Marshall Bancorp Inc is a bank holding company. Through its banking subsidiary, it offers banking products and financial services to small to medium-sized businesses, professional corporations, non-profits, and individuals. The products and services offered by the company include commercial checking, savings, and money market accounts, certificates of deposit, treasury and cash management services, commercial and industrial loans, commercial real estate loans, residential and commercial construction and development loans, online banking, and mobile banking. The firm serves local businesses, professionals, individuals, and families throughout the Washington, D.C. metropolitan area.

Share on Social Networks: